Literature DB >> 23546024

Cytochrome P450 drug interactions with statin therapy.

Ivanna Xin Wei Goh1, Choon How How, Subramaniam Tavintharan.   

Abstract

Statins are commonly used in the treatment of hyperlipidaemia. Although the benefits of statins are well-documented, they have the potential to cause myopathy and rhabdomyolysis due to the complex interactions of drugs, comorbidities and genetics. The cytochrome P450 family consists of major enzymes involved in drug metabolism and bioactivation. This article aims to highlight drug interactions involving statins, as well as provide updated recommendations and approaches regarding the safe and appropriate use of statins in the primary care setting.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23546024     DOI: 10.11622/smedj.2013044

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  8 in total

Review 1.  Rhabdomyolysis: pathogenesis, diagnosis, and treatment.

Authors:  Patrick A Torres; John A Helmstetter; Adam M Kaye; Alan David Kaye
Journal:  Ochsner J       Date:  2015

2.  Multimorbidity, polypharmacy and primary prevention in community-dwelling adults in Quebec: a cross-sectional study.

Authors:  Tu N Nguyen; Patrice Ngangue; Jeannie Haggerty; Tarek Bouhali; Martin Fortin
Journal:  Fam Pract       Date:  2019-11-18       Impact factor: 2.267

Review 3.  Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials.

Authors:  Brian R Ott; Lori A Daiello; Issa J Dahabreh; Beth A Springate; Kimberly Bixby; Manjari Murali; Thomas A Trikalinos
Journal:  J Gen Intern Med       Date:  2015-01-10       Impact factor: 5.128

4.  Colchicine triggered severe rhabdomyolysis after long-term low-dose simvastatin therapy: a case report.

Authors:  Clara Frydrychowicz; Bastian Pasieka; Matthias Pierer; Wolf Mueller; Sirak Petros; Lorenz Weidhase
Journal:  J Med Case Rep       Date:  2017-01-04

5.  Acute Colchicine-induced Neuromyopathy in a Patient Treated with Atorvastatin and Clarithromycin.

Authors:  José M Olmos-Martínez; Helena Molina; Cristina Salas; José M Olmos; José L Hernández
Journal:  Eur J Case Rep Intern Med       Date:  2019-03-18

Review 6.  Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter?

Authors:  Enrica Rossini; Federico Biscetti; Maria Margherita Rando; Elisabetta Nardella; Andrea Leonardo Cecchini; Maria Anna Nicolazzi; Marcello Covino; Antonio Gasbarrini; Massimo Massetti; Andrea Flex
Journal:  Int J Mol Sci       Date:  2022-08-18       Impact factor: 6.208

7.  Metabolism and Metabolic Inhibition of Xanthotoxol in Human Liver Microsomes.

Authors:  Zhongnv Ma; Xianbao Shi; Gang Zhang; Feng Guo; Lina Shan; Jiqun Cai
Journal:  Evid Based Complement Alternat Med       Date:  2016-03-10       Impact factor: 2.629

8.  Fentanyl Enhances Hepatotoxicity of Paclitaxel via Inhibition of CYP3A4 and ABCB1 Transport Activity in Mice.

Authors:  Jing-Dun Xie; Yang Huang; Dong-Tai Chen; Jia-Hao Pan; Bing-Tian Bi; Kun-Yao Feng; Wan Huang; Wei-An Zeng
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.